ARID1A mutations in cancer: another epigenetic tumor suppressor? - Wikidata - thesis-toulmin - TriplyDB

ARID1A mutations in cancer: another epigenetic tumor suppressor?

ARID1A mutations in cancer: another epigenetic tumor suppressor?

http://www.wikidata.org/entity/Q28280605

about

Revealing the Complexity of Breast Cancer by Next Generation Sequencing The mutational landscape of hepatocellular carcinoma New and emerging factors in tumorigenesis: an overview Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.From integrative genomics to therapeutic targets Epigenetic Therapeutics: A New Weapon in the War Against Cancer Genetic alterations in hepatocellular carcinoma: An update From neural development to cognition: unexpected roles for chromatin.Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.Integrated Molecular Characterization of Uterine Carcinosarcoma.Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.Emerging landscape of oncogenic signatures across human cancers.Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors An ancient Pygo-dependent Wnt enhanceosome integrated by Chip/LDB-SSDP.Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer.Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas.Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.ARID1A and TERT promoter mutations in dedifferentiated meningioma.Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome The roles of ARID1A in gynecologic cancer.BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma.miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.The ISG15-specific protease USP18 regulates stability of PTEN.

P2860

Q26777395-5B0FB854-013B-4A08-A07C-F53B5C7E425B Q26777478-39D662F7-7533-4A34-8F0C-D1D5B667AF3E Q26801253-E4289626-205E-45C0-B870-0F93CCC05CEE Q26827810-FB36028F-6812-47FD-B940-A1BBDD9DFF2F Q26862726-F65CCBA8-4069-4617-80AF-CE716023FFEC Q28072370-63A2DF40-20C1-45B9-BB1D-6A700E6B1DF7 Q28073241-822AF696-E03F-4B2E-A047-D88FF1CF1875 Q33567755-4A5B7698-0426-4167-A576-F0F11EEB3103 Q34459131-8A292663-0247-49BB-9C73-12DE07F52B19 Q34681051-B4709398-9803-4FC0-A3B2-3735543BE3F6 Q35020913-46C5DEB3-CFDC-4047-9C00-A8F5D7290795 Q35058708-26B17F03-25F1-4858-89DB-B180369A7C3E Q35632953-133B914A-E051-4940-A6F8-F715F310945D Q35671373-FBFA3F2B-A31D-4218-A21E-B85BABC596CB Q35759295-B697698C-25C4-47E8-89E9-EEBCEF1E8F98 Q35836542-02995A91-BFA4-4E14-A24F-0EA103211393 Q36064635-D68A6146-6FDB-40F3-B26C-1627A0B14DAE Q36188947-8C996297-FBFA-4E8C-BB6D-7E72E46E6EFE Q36416461-7D49259C-452A-4FD4-8576-26D687FF79B8 Q36441526-CDE81746-7521-4E26-90FE-5794006E9446 Q36469778-9CD9CB50-8BB5-4843-9B80-33EFE6492662 Q36533260-B610D334-B230-4CE8-8097-2F6B54A5ACBC Q36629514-86D177C9-5F4E-4D10-AE7A-7535C98076BC Q36685471-2C69CE3F-7448-44D1-AED3-24AD1AC4DCCA Q36850060-C02B27B6-5E6C-4AE2-9B89-D87580CC3173 Q36942228-A5EA0D93-CE11-4246-8366-1FB20A60A29D Q37050045-3A2D147B-DBF4-4718-BBF3-DA60DD8A5618 Q37150061-E46E0C40-EF8F-4C19-96FB-C2CDC2FF4303 Q37166723-B2C75206-B228-4C75-9C0F-D2B8BEF13012 Q37196672-E435AAF6-DCE2-44A1-9BC0-20BA3C7F3A06 Q37225222-0D4AFA31-1BC8-43A7-A0D9-91431F30D4A8 Q37246532-A8F7009F-E625-4F27-8400-54BCB6757493 Q37249318-57396A76-ABC3-4A4E-9405-B4FE905B94C0 Q37264934-569B6B26-74B5-4964-8BB3-ECD1B7B4E0FD Q37528345-96B39391-B46D-481D-B8D9-065FD4F6AC67 Q37564670-7255CA7E-3EEC-4D04-823B-85A156466178 Q37627446-480D0F97-CA7B-4675-8DE1-DE51EB766327 Q37636790-695E1D3A-87A1-4528-8473-C08FDA13B4C1 Q37665574-84BA3B95-DAB5-4B46-90ED-35B10EBC9E17 Q37702220-A445D9D4-9C28-42C1-A45F-EE3ECF10DE57

P2860

ARID1A mutations in cancer: another epigenetic tumor suppressor?

http://www.wikidata.org/entity/Q28280605

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@ast

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@en

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@nl

type

label

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@ast

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@en

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@nl

prefLabel

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@ast

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@en

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@nl

P1433

Q28280605-9232FDD6-61AF-40A4-9A0C-6D86DA49C5A5

P1476

Q28280605-1DFA49F6-BE9B-40E8-AEA6-9632ED51B9B7

P2093

Q28280605-4B92A340-BAEA-4336-A765-9350E3FEBA22

P2860

Q28280605-00C58762-CE57-48A5-9AF4-A29EC1AC5730

Q28280605-01B2CA7C-7838-47DD-BC1F-65F02752A630

Q28280605-01CEF7B4-6F51-45C4-9A89-90744910F99B

Q28280605-03B5DEA2-D4AE-4E98-BCC5-42E7DD0FD74D

Q28280605-13DBFC16-01E5-49A3-8E04-565028E8740F

Q28280605-18077B3B-8703-4353-B7B1-DFF71BF9198C

Q28280605-18E76ADD-1E73-4820-94A4-E7637418BA03

Q28280605-2079A3E2-0E86-4ADE-B894-C7F4CB4028BE

Q28280605-22F651E9-37E8-4D9C-94CE-3EAD7693A4CE

Q28280605-2A4CE8A4-A537-4BA8-A29A-7F4D543B6D53

P304

Q28280605-FDAF3859-076B-4B77-826B-F6DAA6BA1F84

P31

Q28280605-71450cf9-2720-4c9f-b1f5-77b2ffa390eb

Q28280605-85569276-37D7-4F64-9BAB-84DC4DBFF01A

P3181

Q28280605-08A39A9E-9F07-4EA9-8779-5B3D661F9D95

Q28280605-2EB83E25-7104-4F29-8FE0-A489AE343D0A

P356

Q28280605-F42429AC-E0AD-4073-B6A9-0A42A10365AA

P407

Q28280605-3F9FF849-5BB0-42C4-B3E6-7BCE11A33178

P433

Q28280605-7676C49B-0DF5-4024-AA10-5F5E6BD4D1FF

P478

Q28280605-53DF315B-3245-4408-9BE4-1303969B7373

P50

Q28280605-A85525A3-A6E3-4A66-8BB7-AE177E9D1A35

P577

Q28280605-BD2075C3-D6E7-4940-8F85-166291AD8194

P698

Q28280605-14A55D50-B1D5-4394-B80E-FED1624B83C0

P932

Q28280605-315792C4-1B82-42F9-B6ED-D20B539605D2

P3181

P356

2159-8290.CD-12-0361

P1433

Cancer Discovery

P1476

ARID1A mutations in cancer: another epigenetic tumor suppressor?

@en

P2093

Jennifer N Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits

Hallmarks of Cancer: The Next Generation

The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity

Large-scale characterization of HeLa cell nuclear phosphoproteins

BRD7 is a candidate tumour suppressor gene required for p53 function

Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors

The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes

A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex

P304

35-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2705879

http://www.w3.org/2001/XMLSchema#string

399165

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/2159-8290.CD-12-0361

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Charles W Roberts

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23208470

http://www.w3.org/2001/XMLSchema#string

P932

3546152

http://www.w3.org/2001/XMLSchema#string